0
0
0
0
1
2
3
$0
Is CoStar Group solid or fragile? The Finex Financial Health Scanner reads CSGP's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2025) | $3.2B |
|---|---|
| Net income | $7.0M |
| Operating margin | -2.2% |
| Net margin | 0.2% |
| Cash and investments | $1.7B |
| Total debt | $993.0M |
| Free cash flow | $442.4M |
| Revenue growth (1 year) | 18.7% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.